These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12210409)

  • 1. Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption.
    Germi R; Crance JM; Garin D; Guimet J; Lortat-Jacob H; Ruigrok RW; Zarski JP; Drouet E
    J Med Virol; 2002 Oct; 68(2):206-15. PubMed ID: 12210409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.
    Wünschmann S; Medh JD; Klinzmann D; Schmidt WN; Stapleton JT
    J Virol; 2000 Nov; 74(21):10055-62. PubMed ID: 11024134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus entry: potential receptors and their biological functions.
    Cocquerel L; Voisset C; Dubuisson J
    J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search of hepatitis C virus receptor(s).
    Flint M; Quinn ER; Levy S
    Clin Liver Dis; 2001 Nov; 5(4):873-93. PubMed ID: 11685799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus.
    Monazahian M; Böhme I; Bonk S; Koch A; Scholz C; Grethe S; Thomssen R
    J Med Virol; 1999 Mar; 57(3):223-9. PubMed ID: 10022791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
    Wellnitz S; Klumpp B; Barth H; Ito S; Depla E; Dubuisson J; Blum HE; Baumert TF
    J Virol; 2002 Feb; 76(3):1181-93. PubMed ID: 11773394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
    Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
    J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
    Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
    J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
    Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
    J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential cellular receptors involved in hepatitis C virus entry into cells.
    Favre D; Muellhaupt B
    Lipids Health Dis; 2005 Apr; 4():9. PubMed ID: 15836798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant hepatitis C virus-envelope protein 2 interactions with low-density lipoprotein/CD81 receptors.
    Urbaczek AC; Ximenes VF; Afonso A; Generoso WC; Nogueira CT; Tansini A; Cappelini LT; Malagó Júnior W; da Silva FH; da Fonseca LM; da Costa PI
    Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):534-42. PubMed ID: 26018451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
    Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
    Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
    Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
    Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
    Morikawa K; Zhao Z; Date T; Miyamoto M; Murayama A; Akazawa D; Tanabe J; Sone S; Wakita T
    J Med Virol; 2007 Jun; 79(6):714-23. PubMed ID: 17457918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo.
    Tan YJ; Lim SP; Ng P; Goh PY; Lim SG; Tan YH; Hong W
    Virology; 2003 Apr; 308(2):250-69. PubMed ID: 12706076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.
    Higginbottom A; Quinn ER; Kuo CC; Flint M; Wilson LH; Bianchi E; Nicosia A; Monk PN; McKeating JA; Levy S
    J Virol; 2000 Apr; 74(8):3642-9. PubMed ID: 10729140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
    Triyatni M; Saunier B; Maruvada P; Davis AR; Ulianich L; Heller T; Patel A; Kohn LD; Liang TJ
    J Virol; 2002 Sep; 76(18):9335-44. PubMed ID: 12186916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
    Ramanathan A; Gusarova V; Stahl N; Gurnett-Bander A; Kyratsous CA
    PLoS One; 2016; 11(4):e0154498. PubMed ID: 27115873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibition of hepatitis C virus E2 binding to CD81.
    VanCompernolle SE; Wiznycia AV; Rush JR; Dhanasekaran M; Baures PW; Todd SC
    Virology; 2003 Sep; 314(1):371-80. PubMed ID: 14517089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle.
    Albecka A; Belouzard S; Op de Beeck A; Descamps V; Goueslain L; Bertrand-Michel J; Tercé F; Duverlie G; Rouillé Y; Dubuisson J
    Hepatology; 2012 Apr; 55(4):998-1007. PubMed ID: 22121002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.